NRT-NMJ-002

N/A

Report date: 2025/09/05 17:57:10

NME

Base Information

Drug NameNRT-NMJ-002

Drug Alias NameNRT-NMJ-002

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionDNA modification methylases inhibitors

TargetsDNA modification methylases

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNEORNAT Inc

China Registration ClassN/A

Active CompaniesNEORNAT Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A